FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)

View source ↗

Summary

The FDA is reviewing a supplemental application for ARISTADA (aripiprazole lauroxil) submitted by Alkermes, Inc. for potential changes or additions to the produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARISTADA (ARIPIPRAZOLE LAUROXIL)

Snippet

SUPPL AP for ARISTADA (ARIPIPRAZOLE LAUROXIL)